FINWIRES · TerminalLIVE
FINWIRES

NSE:DABUR

4 stories mentioning NSE:DABURUpdated 13d ago

Every FINWIRES story that references NSE:DABUR, newest first.

Asia

Dabur India Sees Limited Impact of Indian Food Regulator's Ban on Some Product Labels

Dabur India (NSE:DABUR, BOM:500096) sees limited impact of the Food Safety and Standards Authority of India (FSSAI)'s recent order that prohibits the company from selling certain products such as honey, cow ghee, and edible oils for using misleading claims."The impact on the Company's business operations, financial position or performance is limited to objected food products only," the company said in a clarification statement on Tuesday.The company has refuted claims made by the FSSAI in its recent order, which forbids Dabur India from selling products with '100%' claims, saying that such labelling is against the law.The company said it had also clarified to an earlier FSSAI notice dated April 8 that no such claim of "100% Pure" is being used on the objected products' labels.However, it added that the company had already started transitioning the product labels as mentioned in the FSSAI letter to new labels and advertisements without the 100% claim.The company is also seeking legal advice on the future course of action.

BOM:500096NSE:DABUR
Asia

Dabur India Partners With GreenLine to Deploy LNG Trucks

Dabur India (NSE:DABUR, BOM:500096) partnered with GreenLine Mobility Solutions to deploy LNG-powered trucks across its logistics network as part of efforts to reduce supply chain emissions, according to a Wednesday press release.Under the partnership, GreenLine Mobility Solutions, an Essar Group venture, will provide LNG-powered trucks for Dabur India's long-haul freight operations.The initiative is intended to reduce emissions while maintaining logistics efficiency and reliability.

BOM:500096NSE:DABUR
Asia

US FDA Issues Import Alert for Dabur India's Silvassa Plant Products

The US Food and Drug Administration (US FDA) has issued an import alert for drugs manufactured by Dabur India (NSE:DABUR, BOM:500096) at its manufacturing plant in Silvassa, Dadra and Nagar Haveli in India, according to a Thursday regulatory filing with Indian stock exchanges.The consumer goods and healthcare major clarified that the detention order applies strictly to a small subset of the Silvassa unit responsible for manufacturing specific private label products. Dabur emphasized that the affected product segment generates insignificant revenue for the company.Domestic products were not covered by the order and therefore were not impacted, and the plant continues to be operational. The company is also taking action to implement alternative sourcing strategies for its US customers."We are continuing to engage with the US FDA authority by providing corrective and preventive action plans along with proactive and strong action on the ground to fix the identified gaps," Dabur said.The company's shares were up nearly 1% in recent trade.

BOM:500096NSE:DABUR
Asia

Dabur India's Consolidated Attributable Profit Grows in Fiscal Q4

Dabur India's (NSE:DABUR, BOM:500096) consolidated attributable profit increased to 3.69 billion Indian rupees from 3.20 billion rupees a year ago, according to a Thursday filing to the Indian stock exchanges.Earnings per share climbed to 2.07 rupees from 1.80 rupees a year earlier, the fast-moving consumer goods giant said.Revenue from operations in fiscal Q4 also rose to 30.4 billion rupees from 28.3 billion rupees a year ago.The company's board recommended a final dividend of 5.50 rupees per equity share having a face value of 1 rupee each for the financial year 2025-26.

BOM:500096NSE:DABUR

Track with the FINWIRES app suite